Matches in Nanopublications for { ?s ?p "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 17 of
17
with 100 items per page.
- assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP745069.RA_vyeSzlSJs6nbBzkTV0czxTbMXTEv1PZiZxU1ZlchZs130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP745069.RA_vyeSzlSJs6nbBzkTV0czxTbMXTEv1PZiZxU1ZlchZs130_provenance.
- NP448120.RAe0YhRhQud8rjUJbt7mWxpXmSxO_aBR1DZ484bU_CllY130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448120.RAe0YhRhQud8rjUJbt7mWxpXmSxO_aBR1DZ484bU_CllY130_provenance.
- NP554245.RAeH3EHcGgDDp5hpr9LsA8U88jR_gzsnXMEO7_X6r3hT4130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554245.RAeH3EHcGgDDp5hpr9LsA8U88jR_gzsnXMEO7_X6r3hT4130_provenance.
- NP707605.RAeH2LClkkNuEzBtK7_YjWB8Zd0lix3RDtCqc50f6RsT4130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707605.RAeH2LClkkNuEzBtK7_YjWB8Zd0lix3RDtCqc50f6RsT4130_provenance.
- NP945971.RATBI0XeGs_WSmJ44iEL3hwnMl89-znf2-kRXQisnXd5Y130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945971.RATBI0XeGs_WSmJ44iEL3hwnMl89-znf2-kRXQisnXd5Y130_provenance.
- assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1001864.RAY8PLxPRAZAjaVScyMReSLQ9bheIu2qCAFcPkK5-zJWg130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001864.RAY8PLxPRAZAjaVScyMReSLQ9bheIu2qCAFcPkK5-zJWg130_provenance.
- NP1001867.RAXzZ0Qh3wZORGo1YuagV1hkRBJcYjeSpTDkZP2nDDMGs130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001867.RAXzZ0Qh3wZORGo1YuagV1hkRBJcYjeSpTDkZP2nDDMGs130_provenance.
- NP1001868.RAriCO4vb5OYf1I5kv0OCpZa-N2ElqKOThj_iJQGAYUIg130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001868.RAriCO4vb5OYf1I5kv0OCpZa-N2ElqKOThj_iJQGAYUIg130_provenance.
- NP1001874.RArYw9IGKWLyQabt3iQ5_eiOYyPOJSdK3k5ykYGDfd6R8130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001874.RArYw9IGKWLyQabt3iQ5_eiOYyPOJSdK3k5ykYGDfd6R8130_provenance.
- NP498756.RAxdpmoUrdTY2FA-oxoaAuUwXqthC-AVnuhiL8DUF-TvU130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498756.RAxdpmoUrdTY2FA-oxoaAuUwXqthC-AVnuhiL8DUF-TvU130_provenance.
- NP1001869.RAPLoAMOVmOnXKwwQIkLFSNqXA2KcGvY3zLIOFZfQPnG0130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001869.RAPLoAMOVmOnXKwwQIkLFSNqXA2KcGvY3zLIOFZfQPnG0130_provenance.
- NP803028.RA--ENoK6dPAAScc9RxGWsIWjgvgaAUK9J8tbcrb78TKk130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803028.RA--ENoK6dPAAScc9RxGWsIWjgvgaAUK9J8tbcrb78TKk130_provenance.
- NP1001871.RA07CmGIp5F1EP7TgcidTrcR-_xlZIjzaPAnyRx-V9IE4130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001871.RA07CmGIp5F1EP7TgcidTrcR-_xlZIjzaPAnyRx-V9IE4130_provenance.
- NP1001873.RA0My3hP1V0mz3Snn-P4-wfiGf7HpzhuxgrWkXtdP3E-I130_assertion description "[Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001873.RA0My3hP1V0mz3Snn-P4-wfiGf7HpzhuxgrWkXtdP3E-I130_provenance.